ArticleTranslational vision science & technology2026
Toward Organelle Motility as a Functional Biomarker of Retinal Pigment Epithelium Health.
Article in Translational vision science & technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The purpose of this study was to quantify characteristics of retinal pigment epithelium (RPE) organelle motility in human subjects across the temporal (T) macula. Methods: In 11 healthy volunteers (HVs), we used high-speed adaptive optics-optical coherence tomography (AO-OCT) to image RPE cells from the fovea to 12°T. Organelle motility was calculated in the apical, middle, and basal layers as the time constant (τ) of the exponentially decaying speckle decorrelation function normalized to the photoreceptor layer. We imaged 7 HVs on 3 different days at the fovea and 7.5°T to characterize motility repeatability. We imaged 4 HVs on 2 systems with 830 nm and 1060 nm source wavelengths at 7.5°T to explore motility wavelength dependence. Results: Across the temporal macula, τ decreased from 15.3 (±2.4) to 10.9 (±2.7) seconds (-0.33 seconds/degrees) for the apical RPE, decreased from 9.4 (±1.8) to 8.5 (±1.9) seconds (-0.11 seconds/degrees) for the middle RPE, and was nearly constant (-0.05 seconds/degrees) at 6.7 (±1.0) seconds for the basal RPE at 1060 nm. Motility repeatability was moderate (coefficient of variance [CV] = 10.7% for all subjects and locations). At all RPE layers, τ measured shorter at 830 nm (apical = 6.8 ± 2.2, middle = 4.8 ± 1.0, and basal = 3.8 ± 0.7 seconds) compared with 1060 nm (apical = 10.4 ± 2.8, middle = 6.5 ± 1.6, and basal = 5.0 ± 1.1 seconds, P < 0.005). Conclusions: RPE organelle motility varies across the macula and cell depth. Our normative dataset will aid future studies of RPE-related retinal pathology. Translational Relevance: AO-OCT measured organelle motility is a potential functional biomarker of RPE cell health and ocular disease pathophysiology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.